Intellia Thera CS (NQ: NTLA )
23.06
-0.22
(-0.95%)
Streaming Delayed Price
Updated: 11:16 AM EDT, Jun 11, 2024
Add to My Watchlist
Headline News about Intellia Thera CS
![](https://cdn.benzinga.com/files/images/story/2023/Cathie_Wood_Ark_Photo_courtesy_Benzinga_YouTube_and_Unsplash_30.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2019/07/biotech1600-1.jpg)
![](https://g.foolcdn.com/editorial/images/745456/gettyimages-1442947197.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
The Latest Analyst Ratings for Intellia Therapeutics
August 29, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/Cathie_Wood_Ark_Photo_courtesy_Benzinga_YouTube_and_Unsplash_29.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Preview: Intellia Therapeutics's Earnings
August 02, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/Cathie_Wood_Ark_Photo_courtesy_Benzinga_YouTube_and_Unsplash_28.jpeg?width=1200&height=800&fit=crop)
Cathie Wood's Ark Invest Adjusts Portfolio — Sells Nvidia Shares Worth Nearly $1.9M Amid AI Surge
August 24, 2023
Via Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
![](https://g.foolcdn.com/editorial/images/745136/gettyimages-1425565570.jpg)
![](https://g.foolcdn.com/editorial/images/745119/gettyimages-1206327647.jpg)
![](https://g.foolcdn.com/editorial/images/744604/doctor-and-patient-in-a-hospital-room.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/Cathie_Wood_Ark_Invest_7.png?width=1200&height=800&fit=crop)
Cathie Wood Mops Up $8.1M Worth Of Zoom Stock After Q2 Earnings Beat, Sells Nvidia Shares In Excess Of $1M
August 22, 2023
Via Benzinga
Topics
Earnings
Exposures
Financial
![](https://g.foolcdn.com/editorial/images/738729/biotech-researcher.jpg)
![](https://g.foolcdn.com/editorial/images/744754/healthcare.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/Cathie_Wood_Ark_Photo_courtesy_Benzinga_YouTube_and_Unsplash_27.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/Cathie_Wood_Photo_courtesy_Benzinga_YouTube_and_Shutterstock_6.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/Cathie_Wood_Ark_Photo_courtesy_Benzinga_YouTube_and_Unsplash_26.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/Cathie_Wood_Ark_Photo_courtesy_Benzinga_YouTube_and_Unsplash_23.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/10/droplet-test-tube-biotech-1600-3.jpg)
![](https://investorplace.com/wp-content/uploads/2019/07/biotech1600molecule.jpg)
![](https://investorplace.com/wp-content/uploads/2020/07/biopharma-1600.jpg)
![](https://g.foolcdn.com/editorial/images/738041/mna.jpg)
![](https://g.foolcdn.com/editorial/images/737749/3-worried-investors-talk-at-a-table.jpg)
![](https://cdn.pixabay.com/photo/2018/07/15/10/44/dna-3539309_960_720.jpg)
![](https://g.foolcdn.com/editorial/images/737213/smiling-man-holding-fist-up.jpg)
![](https://g.foolcdn.com/editorial/images/737372/doctor-explains-paper-to-patient.jpg)
![](https://g.foolcdn.com/editorial/images/736669/investor-considers-papers-at-a-cafe.jpg)
![](https://g.foolcdn.com/editorial/images/736683/african-american-young-couple-dancing.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.